THRX:
Analysis & Opinions
-
July 02, 2012
The market is currently down, with the Nasdaq falling 0.2%, the S&P 500 down 0.2% and the Dow decreasing 0.5%. The ...
-
June 19, 2012
We have maintained our Neutral recommendation on Theravance, Inc. (THRX) with a target price of $20.00 per share. ...
-
June 13, 2012
GlaxoSmithKline (GSK) recently announced that its subsidiary, Stiefel, has entered into an agreement with Basilea ...
-
March 19, 2012
Some value investors stay out of the spotlight. Seth Klarman is one of those under-the-radar names.
-
December 08, 2009
It's always a good idea to watch the pros, especially guys like Seth Klarman.
